- Fee assured
- Verified this account
This healthcare professional let us know that they are currently:
- Accepting new patients
- Available for:
- Face-to-face consultations
- Phone consultations
- Video consultations
Last updated: 26 May 2020
- Substance misuse psychiatry
Dr Oscar D'Agnone MD MRCPsych is one of the most senior and respected psychiatrists and medical addiction specialists in the UK specialising in anxiety disorders, addictions, alcohol-related problems, trauma (PTSD), depression and ADHD. He is currently CEO and Medical Director of Seagrave Healthcare/The OAD Clinic, a leading private institution providing mental health and addiction treatment in central London for over 15 years.
Until November 2018 Dr D'Agnone has been Honorary Professor of the Faculty of Medical and Human Sciences at the University of Manchester, member of the Royal College of Psychiatrists and the International Society of Addiction Medicine.
With over 35 years of experience as a consultant psychiatrist treating patients with mental health and addiction problems, Dr D'Agnone provides complex psycho-neuropharmacological interventions to manage or resolve challenging situations for his patients and their families suffering the consequences of mental health problems. Throughout his career he has held many managerial positions, leading large teams of doctors, nurses and psychologists through various treatment settings across Europe and America. As a result, he has obtained a rich clinical experience that has allowed him to develop and offer a problem-focused pragmatic approach to the variety of pharmacological and psychosocial interventions for his patients.
Dr D'Agnone has taught in many European and American universities and institutions and published numerous medical papers and books on addictions and has published widely in the professional medical press. In addition, he often presents at noteable national and international scientific conferences and is the senior adviser for various governments and pharmaceuticals on policy strategy and the research and development of new drugs.
Areas of interest
opioid dependence; alcohol dependence; alcohol; drug misuse; drug dependence; addictions; adults; anxiety disorders; painkiller dependence; painkiller dependence; painkiller addiction; medicinal cannabis; sleeping problems; insomnia; PTSD; alcohol detoxification; alcohol detox; alcohol home detox; drug detox; drug detoxification; opioid detoxification; benzo detox; benzodiazepine detoxification; depression;
Reference number 6042483